Chase Investment Counsel Corp Amgen Inc Transaction History
Chase Investment Counsel Corp
- $296 Million
- Q3 2024
A detailed history of Chase Investment Counsel Corp transactions in Amgen Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 1,574 shares of AMGN stock, worth $412,750. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,574
Previous 1,549
1.61%
Holding current value
$412,750
Previous $483,000
4.97%
% of portfolio
0.17%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,119Shares Held
407MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$13.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$7.69 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$3.85 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.74 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $140B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...